Pediatrix Medical Group (NYSE:MD) Cut to “Underperform” at Mizuho

Pediatrix Medical Group (NYSE:MD) was downgraded by investment analysts at Mizuho from a “neutral” rating to an “underperform” rating in a research note issued to investors on Wednesday, FinViz reports. They currently have a $28.00 price target on the stock. Mizuho‘s target price indicates a potential downside of 11.26% from the company’s current price.

Other equities research analysts have also issued research reports about the company. UBS Group raised their price objective on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Weiss Ratings raised Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, September 9th. Truist Financial upped their target price on Pediatrix Medical Group from $28.00 to $31.00 and gave the company a “hold” rating in a research report on Friday, October 30th. Jefferies Financial Group cut Pediatrix Medical Group from a “buy” rating to a “hold” rating and increased their target price for the company from $27.00 to $28.00 in a research note on Wednesday, August 19th. Finally, Wall Street Zen raised shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 13th. One analyst has rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and an average target price of $28.00.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $31.55 on Wednesday. Pediatrix Medical Group has a 12 month low of $17.23 and a 12 month high of $33.74. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.28 and a quick ratio of 1.28. The firm has a market capitalization of $2.46 billion, a P/E ratio of 17.15 and a beta of 0.62. The company’s fifty day moving average price is $27.60 and its two-hundred day moving average price is $24.19.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Thursday, October 29th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.65 by $0.07. The company had revenue of $501.37 million during the quarter, compared to the consensus estimate of $498.18 million. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. The company’s revenue was up 1.7% on a year-over-year basis. During the same period last year, the firm earned $0.67 earnings per share. On average, research analysts anticipate that Pediatrix Medical Group will post 2.21 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new position in shares of Pediatrix Medical Group during the second quarter worth about $347,383,000. Dimensional Fund Advisors LP increased its holdings in Pediatrix Medical Group by 8.1% in the first quarter. Dimensional Fund Advisors LP now owns 3,856,915 shares of the company’s stock valued at $82,496,000 after buying an additional 287,696 shares during the last quarter. Wasatch Advisors LP increased its holdings in Pediatrix Medical Group by 21.9% in the second quarter. Wasatch Advisors LP now owns 2,498,884 shares of the company’s stock valued at $63,297,000 after buying an additional 448,360 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Pediatrix Medical Group by 27.9% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,070,961 shares of the company’s stock valued at $53,348,000 after buying an additional 452,051 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in Pediatrix Medical Group by 12.9% during the first quarter. Renaissance Technologies LLC now owns 1,532,300 shares of the company’s stock valued at $32,776,000 after buying an additional 174,600 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company’s services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.